Clorazepate (Tranxene(R))

The Clorazepate (Tranxene(R)) test contains 1 test with 1 biomarker.

Orally administered clorazepate is rapidly decarboxylated to its metabolite, nordiazepam. There is essentially no circulating patent drug. Nordiazepam elimination half-life is about 40 to 50 hours. Plasma levels of nordiazepam increase proportionally with clorazepate dose and show moderate accumulation with repeated administration.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Clorazepate TranxeneR

Nordiazepam

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.